Form 8-K - Current report:
SEC Accession No. 0000950170-24-134767
Filing Date
2024-12-10
Accepted
2024-12-10 08:15:19
Documents
21
Period of Report
2024-12-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sclx-20241210.htm   iXBRL 8-K 44699
2 EX-99.1 sclx-ex99_1.htm EX-99.1 47080
3 EX-99.2 sclx-ex99_2.htm EX-99.2 43368
4 GRAPHIC img191798281_0.jpg GRAPHIC 14272
5 GRAPHIC img191798281_1.jpg GRAPHIC 8177
6 GRAPHIC img191798281_2.jpg GRAPHIC 11277
7 GRAPHIC img191798281_3.jpg GRAPHIC 17053
8 GRAPHIC img192721802_0.jpg GRAPHIC 14272
9 GRAPHIC img192721802_1.jpg GRAPHIC 8177
10 GRAPHIC img192721802_2.jpg GRAPHIC 11277
11 GRAPHIC img192721802_3.jpg GRAPHIC 17053
  Complete submission text file 0000950170-24-134767.txt   460242

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sclx-20241210.xsd EX-101.SCH 60677
23 EXTRACTED XBRL INSTANCE DOCUMENT sclx-20241210_htm.xml XML 6490
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 241537188
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)